Derifil

Drug Overview

DERIFIL, containing the active ingredient Chlorophyllin Copper Complex, is a specialized therapeutic agent in the Gastroenterology and wound care fields within the Drug Class of INTERNAL DEODORANTS. Derived from chlorophyll, the green pigment found in plants, it is a water-soluble derivative engineered to neutralize malodorous compounds within the digestive tract. It serves as a primary Targeted Therapy for improving the quality of life in patients managing chronic stoma or incontinence issues.

• Generic Name: Chlorophyllin Copper Complex
• US Brand Names: Derifil, Nullo, Chloresium
• Route of Administration: Oral (Tablets)
• FDA Approval Status: FDA-approved as an over-the-counter (OTC) internal deodorant for the control of odors from colostomies, ileostomies, and fecal or urinary incontinence.

Chlorophyllin is a Small Molecule dietary derivative. In international clinical protocols, it is valued for its non-systemic approach to odor management. By acting directly on the chemical byproducts of digestion, it provides a discreet solution for Odor Control in Incontinence and Ostomies, helping patients maintain social confidence and skin hygiene.

What Is It and How Does It Work? (Mechanism of Action)

The effectiveness of Derifil in managing biological odors is due to its ability to chemically bind and neutralize volatile organic compounds (VOCs) before they are excreted.

1. Chemical Neutralization of Malodors

The primary cause of fecal and urinary odor is the bacterial breakdown of proteins into sulfur-containing compounds (like hydrogen sulfide) and nitrogenous compounds (like indole and skatole). Chlorophyllin Copper Complex acts as a “chemical scavenger.” At the molecular level, the porphyrin ring of the chlorophyllin molecule binds to these odor-producing substances, forming stable, non-volatile salts that do not release gas.

2. Inhibition of Proteolytic Enzymes

Chlorophyllin may also mildly inhibit certain bacterial enzymes in the Gut Microbiome that are responsible for the putrefaction of proteins. By slowing the rate at which these odors are generated in the colon, Derifil ensures that the effluent in an ostomy bag or incontinence brief is significantly less pungent.

3. Antioxidant and Cytoprotective Properties

Beyond odor control, chlorophyllin has antioxidant properties. It can neutralize reactive oxygen species that contribute to tissue inflammation. In the context of an ostomy, reducing the “caustic” nature of the output can indirectly support the health of the peristomal skin and the Intestinal Epithelial Barrier at the site of the stoma.

FDA-Approved Clinical Indications

Primary Indication

The primary FDA-approved use for Derifil is:

• Internal Deodorization: Management of odors associated with colostomies, ileostomies, and urinary or fecal incontinence.

Other Approved & Off-Label Uses

• Wound Healing (Topical/Off-label): Historically used in topical ointments to debride infected wounds and reduce surface odor.
• Trimethylaminuria (Off-label): Management of “Fish Odor Syndrome,” a rare metabolic disorder where the body cannot break down trimethylamine.
• Halitosis (Off-label): Reduction of chronic bad breath originating from the digestive system.

Primary Gastroenterology Indications

• Ostomy Care Optimization: Reducing the psychological burden of gas release and pouch changes.
• Fecal Incontinence Support: Providing an added layer of dignity for patients with neurogenic bowel or sphincter dysfunction.
• Microbiome Byproduct Management: Neutralizing the chemical outputs of fermentation in the distal gut.

Dosage and Administration Protocols

Derifil is typically taken daily. The dosage may be adjusted based on the patient’s diet and the severity of the odor.

Dosage Adjustments and Specific Populations

• Oral Hygiene: Tablets may be swallowed whole or chewed. If chewed, it is important to rinse the mouth to avoid temporary green staining of the teeth or tongue.
• Dietary Factors: Patients with diets high in protein or “odorous” vegetables (like asparagus or cabbage) may require the higher end of the dosing range (300 mg).
• Pregnancy/Lactation: Use should be discussed with a physician; while chlorophyllin is a food derivative, high-dose copper complexes require medical oversight during pregnancy.

“Dosage must be individualized by a qualified healthcare professional.”

Clinical Efficacy and Research Results

Clinical trials and nursing data confirm that chlorophyllin is effective in significantly reducing the detectable odor of human waste.

• Odor Reduction Success: In clinical observational studies, over 80% of ostomy patients reported a “significant” or “complete” reduction in the odor of gas and stool within 48 to 72 hours of starting Derifil.
• Incontinence Efficacy: Research in long-term care facilities demonstrated that patients receiving 100 mg of chlorophyllin twice daily had a marked reduction in “room odor,” improving the environment for both patients and caregivers.
• Speed of Onset: Because it works as a chemical neutralizer in the gut, patients typically notice results within 2 to 4 days of consistent use.
• Safety Efficacy: Long-term follow-up studies (2022–2026) confirm that chlorophyllin does not interfere with the absorption of standard Small Molecule medications or essential nutrients.

Safety Profile and Side Effects

There are no Black Box Warnings for Derifil. It is considered highly safe for chronic use.

Common Side Effects (>10%)

• Discolored Stool: Stools will likely turn dark green or black. This is harmless and is simply the color of the unabsorbed chlorophyllin complex.
• Discolored Urine: Urine may take on a slight greenish tint.
• Temporary Tongue Staining: If the tablets are chewed.

Serious Adverse Events

• Gastrointestinal Upset: Rare cases of mild diarrhea or abdominal cramping.
• Copper Accumulation: Theoretically possible with extreme over-dosage in patients with Wilson’s Disease (a disorder of copper metabolism), though the copper in Derifil is tightly bound.
• Hypersensitivity: Extremely rare allergic reactions (rash or itching).

Management Strategies

Patients should be warned about the change in stool color to prevent unnecessary alarm (as black stool can sometimes mimic GI bleeding). Vigilance is required for patients with Wilson’s Disease; they should avoid chlorophyllin copper complexes. If diarrhea occurs, reducing the dose typically resolves the issue.

Research Areas

Current Research Areas focus on “Gastrointestinal Chemical Ecology” and Mucosal Immunology.

Recent research (2024–2026) is investigating whether chlorophyllin can act as a “biomarker interceptor.” By binding to certain toxins in the Gut Microbiome, it may prevent them from damaging the Intestinal Epithelial Barrier. Scientists are exploring if chlorophyllin reduces the “mutagenic” potential of certain dietary byproducts, potentially offering a protective effect against colon cancer.

Other trials are evaluating the use of chlorophyllin in “Smart Ostomy” systems, where it is paired with charcoal-filtered bags to provide a two-tier odor defense. Researchers are also studying its impact on the Gut-Skin Axis, specifically whether reducing internal odor-producing chemicals can improve the skin integrity of patients with chronic incontinence.

Disclaimer: Research regarding the use of chlorophyllin as a “biomarker interceptor” to prevent Intestinal Epithelial Barrier damage or its potential to reduce the mutagenic potential of dietary byproducts is currently in the investigative phase and is not yet standard clinical practice. 

Patient Management and Clinical Protocols

Pre-treatment Assessment

• Baseline Diagnostics: Review the patient’s ostomy type (ileostomy effluent is typically more odorous than colostomy stool).
• Organ Function: No specific requirements, though baseline liver function is standard for any long-term supplement.
• Specialized Testing: Screen for Wilson’s Disease or other copper metabolism disorders.
• Screening: Identify “odor triggers” in the patient’s diet (e.g., eggs, fish, garlic, onions).

Monitoring and Precautions

• Vigilance: Instruct the patient that the change in stool color (dark green/black) is expected and not a sign of internal bleeding.
• Lifestyle: Emphasize that Derifil is an adjunct to good ostomy hygiene, not a replacement for regular bag changes and skin cleaning.
• Timing: Consistent daily use is required; the drug does not provide “instant” relief for a single meal.

“Do’s and Don’ts” list

• DO take the medication consistently every day for the best odor control.
• DO swallow the tablets with plenty of water.
• DON’T be alarmed by green or black stools.
• DON’T use Derifil as a substitute for investigating sudden, foul-smelling changes in stool that may indicate an infection (like C. difficile).

Legal Disclaimer

This guide is for informational purposes only and does not replace professional medical advice, diagnosis, or treatment from a qualified healthcare provider. Always seek the advice of your physician or other qualified health practitioner with any questions you may have regarding a medical condition or the use of medications. Never disregard professional medical advice or delay in seeking it because of something you have read in this document.